Craft

Shanghai RAAS

Stock Price

¥7.5

2024-10-29

Market Capitalization

¥48.8 B

2024-10-29

Revenue

¥7.3 B

FY, 2025

Shanghai RAAS Summary

Company Summary

Overview
Shanghai RAAS Blood Products (上海莱士血液制品股份有限公司) is a company researching, inventing, and developing products for the treatment of blood diseases. It offers several categories of blood products: human blood proteins, human immunoglobulin, and blood coagulation factors.
Type
Public
Status
Active
Founded
1988
HQ
CN | view all locations
Website
https://www.raas-corp.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Shang Hai Shi HQ

    China

    Wang Yuan Lu, Feng Xian Qu

Shanghai RAAS Financials

Summary Financials

Revenue (Q1, 2026)
¥1.5B
Gross profit (Q1, 2026)
¥551.9M
Net income (Q1, 2026)
¥315.8M
Cash (Q1, 2026)
¥1.9B
EBIT (Q1, 2026)
¥320.1M
Enterprise value
$50.9B

Footer menu